Currently there are four pharmaceutical companies working to
develop medications that are specifically designed to treat migraines. This way migraine sufferers won’t have to
take something like heart medication to treat their migraines and then have to
worry about the side effects of taking a medication for a condition you don’t
have.
The four companies working on the new drugs, Alder
BioPharmaceuticals, Amgen, Eli Lilly and Teva, are all developing slightly
different antibodies, administered at different times. Meaning some are monthly injections, some are
injections given every 3 months and others are in pill form.
Most of these companies are in stage three of their clinical
trials and so far they are getting very good results and the medications are
showing little to no side effects. The
down side to the new medications is they are made from living cells which makes
them very expensive to produce. They are
estimated to cost anywhere between $8000 and $20,000 a year which means
insurance companies aren’t going to be jumping up to pay for them. Which means they will want you to exhaust all
other options as well as meet other qualifying factors before they will even
consider covering any of the cost for these new medications. Just like it is with Botox now.
These new medications are expected to hit the market in 2019
(hopefully). I am excited for the
possibility the medications might bring and am happy there is hope but these
meds are still 3 years out and when you’re in constant pain 3 years seems like
an eternity.

No comments:
Post a Comment